Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I thought he did more than enough when he gutted our nations pandemic response team.
Agreed.
"I'm not that optimistic about hydroxychloroquine. It's not really clear it's having a clinic effect," former FDA Commissioner Scott Gottlieb said Wednesday. "I hope it works, but I think a lot of the enthusiasm is because it's available, so people are over-interpreting the data, because it's on the shelf."
"I'm not that optimistic about hydroxychloroquine. It's not really clear it's having a clinic effect," former FDA Commissioner Scott Gottlieb said Wednesday. "I hope it works, but I think a lot of the enthusiasm is because it's available, so people are over-interpreting the data, because it's on the shelf."
I was just about to post a link to that article. It seems the mortality rate could be as high as 90% once you are put on a ventilator.
We’re talking prophylaxis treatment if these results continue. This is HUGE!!
Head-faked the share price up $0.20+ premarket.
Thanks for your continued posting and responses from others. It only serves to bring more attention to this message board and the company. Appreciate your efforts in promoting this stock!
I can only imagine the SP if this goes a prophylaxis route for covid-19.
If/when we uplist, doesn’t every warrant need to be exercised or surrendered?
Based on the early findings in covid-19 patients and how it’s affecting various key inflammatory markers - it looks like we could have another application for sepsis. Your thoughts?
The difference here is that I’m posting about CytoDyn on a CytoDyn message board. You continue to post about other companies on a CytoDyn message board.
The difference here is that I’m posting about CytoDyn on a CytoDyn message board. You continue to post about other companies on a CytoDyn message board.
Am I the only one in awe of the results for the first patient (let alone the rest of them)? You’re talking about people that would be dead right now had it not been for Leronlimab.
One of the best articles I have read that highlights the science.
We will have our day, and I will DEFINITELY have a cold one in my hand!
100% meets the criteria for breakthrough designation. I hate to say this, but if the FDA drags their feet with this drug any further, it will truly highlight their corruption.
“ Early preliminary clinical trial results are very encouraging, and demonstrating that lenronlimab might be a functional cure for metastatic cancer.”
https://medicalnewsfirst.com/the-quest-for-a-functional-cure-in-cancer-reaching-an-inflection-point/
You also have a new 60-day clock ticking for when the FDA has to reply regarding BTD. With data on the newest patients, we could wake up to PR any day saying it was granted. Tick tock.
If there is, I can’t think of it. However, there are much smarter people than myself working on this. I’m sure it will be addressed during the call.
I appreciate the reply. The immune system is a complicated animal - especially when you start studying complements and the like. I have a very basic understanding of the immune system and infectious diseases, so I was curious if PRO-140 could work beyond just a functional cure for HIV. Looks like I’m not the only one with that curiosity. Good luck to you!
Great question
Or, you could just read the link that DocJ posted which has an outline of what to expect on the call.
Amen to that FDA meeting.
Question for you regarding HIV and PRO-140:
Since it has been show to reduce viral load down to 0 - do you think it is theoretically possible that after years of use that PRO-140 could completely eliminate the virus?
It is. It’s 3 PRs down from the top.
It’s almost as if PRO-140 is not only a “functional” cure for HIV, but also for cancer. With HIV, it reduces viral load down to zero detectable copies; however, the virus may be dormant somewhere in the body and eventually be able to replicate. Now with cancer, it is showing zero circulating tumor cells AND a reduction in tumor size. While it may not be able to completely eliminate the tumors, it may allow patients to live without fear of dying from cancer (because it is generally the metastasis of cancer that kills the individual).
Did you say $50? I think you lowballed our company.
And frothy
CytoDyn: We have news and data that PRO-140 continues to show amazing results.
Amateur: But does it cure death yet?
I’m no chartist, nor trader, but I think we’ll see the SP pullback a little further until we get some news about BLA, cancer, etc. However, I’m thinking of adding more to my position at these levels, even with a $0.48 average.
I have been invested with CytoDyn for 5+ years now. My warrants would have expired in December if I did not exercise them. I know there were 2 more raises within 8 months of the one that I participated in. So as I answered: there are plenty of expiring warrants that people would be foolish not to exercise for at least a small profit. Additionally, you have to understand a percentage of Paulson “investors”. Personally, I invested because I understand the science and know that PRO-140 is truly a generational drug. I do not trade the stock and have only added to my position with the open market. That is not the case for most Paulson “investors”. They/we were pitched a risk-free method for investing - which was to dump all your shares and hold the warrants. These “investors” do not understand the science as well as others and are only looking for a way to turn a quick profit.
For the simple fact that most, if not all warrants, are in the money at this moment. They could be exercised and sold for a small profit right now. Warrants also have an expiration and I have to imagine with the raises over the years that there are plenty out there getting ready to expire. It would be silly to not exercise them.
Dr. Nader stated the 87 million financing deal was with upfront and milestone payments. Regarding financials, he said that he is seeing warrants being exercised, which is bringing money in to the company. He also said BLA will be submitted in January.
You may want to re-listen as your notes are misleading.
Of all the stocks mentioned in the article - the author only reports having a position on 1 stock, and that’s long CYDY.
My thoughts exactly.
With the way volume is on no news currently, I can only imagine what the volume would be like if/when a deal is announced.
Do you work with doors for a living, because I see you are particularly adept at handling knobs.
Thanks for the post, Chump. The way Nader positioned a potential licensing deal, again, is not if it happens, but when. Still impatiently waiting.
Saltz- have you spoken with Paulson recently?
Better yet, with such a gloomy outlook of the company - why don’t these “shareholders” sell and move on?
Agreed.
No one in their right mind would own shares if that’s how they felt about the company.
The effort to distract from the facts is embarrassing.